The Energy Code

Dr. Mike Belkowski
  • 4.8 (126)
  • ALTERNATIVE HEALTH
  • UPDATED WEEKLY

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

  1. 16H AGO

    ALS May Start in the Hypothalamus: Early Mitochondrial Failure + Metabolic Circuit Breakdown

    In this Energy Code Deep Dive episode, Dr. Mike unpacks a paper that reframes ALS at a deeper level: ALS may begin as an energy regulation failure, starting in the hypothalamus, before it becomes an obvious motor neuron story.The hypothalamus isn’t just “another brain region”; it’s the body’s metabolic control room — governing hunger, energy expenditure, hormones, and fuel signaling. The paper shows that in ALS mouse models, the hypothalamus develops early mitochondrial bioenergetic impairment (including reduced spare respiratory capacity) alongside neuroimmune activation (astrocytes and microglia) and melanocortin circuit disruption (POMC/AgRP imbalance) that could help explain early hypermetabolism and weight loss seen in ALS. Most provocatively, early metabolic modulation (TMZ) restored hypothalamic bioenergetics, reduced glial activation, normalized aspects of circuit signaling, delayed onset, and extended survival — suggesting the “first domino” may be a failing energy command center, not just downstream motor collapse. (Educational content only, not medical advice.) - Article Discussed in Episode: The hypothalamus is an early site of mitochondrial failure and neuro-immune circuit disruption in amyotrophic lateral sclerosis - Key Quotes From Dr. Mike: “ALS may not begin only as a motor neuron story. It may also begin as an energy regulation story.” “Mitochondrial dysfunction shows up in the hypothalamus before symptoms begin.” “If that is true, then ALS is not just a disease of movement. It is also a disease of failed energy coordination.” “These hypothalamic mitochondrial changes… happened before major motor symptoms.” “…if you intervene early at the level of hypothalamic energy failure, you may be able to change the trajectory of disease.” - Key Points ALS may not start only in motor neurons; it may start with hypothalamic energy-control failure. The hypothalamus is the body’s metabolic thermostat/control room (hunger, weight, hormones, energy use). Hypermetabolism + weight loss are common in ALS and correlate with worse outcomes — this may be upstream, not just secondary. In ALS models, hypothalamus shows early mitochondrial dysfunction before symptom onset. Key mitochondrial finding: reduced maximal respiration + reduced spare respiratory capacity (“backup power” loss). Changes are region-specific: hypothalamus shows the strongest coordinated mitochondrial/inflammatory signature vs hippocampus/cerebellum. Early astrocyte and microglia activation appears alongside metabolic reprogramming toward glycolysis. Melanocortin circuitry disruption: decreased POMC neurons, increased AgRP-related signaling → altered energy balance control. Timing matters: these shifts occur before major motor symptoms, implying causal relevance. TMZ (trimetazidine) given early restored hypothalamic bioenergetics, reduced glial activation, normalized circuit features, delayed onset, extended survival (mouse data). - Episode timeline 0:19–0:34 — Intro + why this paper could change how we think about ALS 0:34–1:55 — The core reframing: ALS as energy coordination failure, not only motor decline 2:02–3:15 — Hypothalamus 101: the body’s metabolic control room + why ALS hypermetabolism matters 3:18–5:43 — Early hypothalamic mitochondrial failure: methods + respiration + spare respiratory capacity explained 5:54–6:50 — Region specificity: why the hypothalamus stands out vs other brain areas 6:55–8:39 — Neuroimmune activation: astrocytes/microglia activation + metabolic shift toward glycolysis 8:41–10:11 — Melanocortin system disruption: POMC/AgRP imbalance as a driver of systemic energy mismanagement 10:15–11:12 — The timing argument: control-system failure may precede visible motor catastrophe 11:23–12:28 — Translational wedge: TMZ restores bioenergetics, calms glia, shifts circuits, delays onset (in mice) 12:48–13:25 — Cross-model relevance: evidence beyond a single ALS model 13:32–16:11 — Final synthesis: ALS as a metabolic command-center disorder plus motor degeneration - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    16 min

  2. 1D AGO

    Methylene Blue + Near-Infrared Light: Two Tools, One Mitochondrial Neuroprotection Mechanism

    In this Energy Code Deep Dive episode, Dr. Mike breaks down a provocative neuroprotection review: low-dose methylene blue and near-infrared (NIR) light may look like totally different therapies — one is a molecule, one is photons — but the paper argues they converge on the same core target: mitochondrial respiration. You’ll hear a simple “neurons as cities / mitochondria as power plants” model for neurodegeneration, why methylene blue can function like an alternate electron shuttle in the electron transport chain, how NIR light can energize cytochrome oxidase, and why both approaches may widen the neuron’s “energy margin” during stress. The takeaway isn’t “magic cures.” It’s a disciplined mitochondrial lens: improving the power supply may give repair, plasticity, and survival systems the bandwidth to work. (Educational content only, not medical advice.) - Article Discussed in Episode: Protection against neurodegeneration with low-dose methylene blue and near-infrared light - Key Quotes From Dr. Mike: “Two very different therapies (methylene blue & NIR light) may be helping the brain in basically the same way.” “Methylene blue, at low doses, appears to help by acting like an alternate electron shuttle.” “This paper makes the point that methylene blue has a hormetic dose response…” “…near infrared light is more like directly energizing one of the key turbines in the mitochondrial power plant.” “Different tools, same target, and that target is mitochondrial respiration.” “…if you can stabilize mitochondrial respiration, you may be able to widen that energy margin and make neurons harder to kill.” - Key Points The paper’s thesis: two very different interventions may protect neurons via the same mitochondrial mechanism. Neurodegeneration framed as energy margin collapse (not only plaques/tangles/toxins/inflammation). Low-dose methylene blue: acts as an alternate electron shuttle → supports electron flow, ATP production. Dose matters: methylene blue shows hormesis (low dose supportive; higher dose can backfire). Near-infrared light: photons absorbed by cytochrome oxidase → boosts mitochondrial respiration and ATP. NIR effects may outlast a session via enzyme induction / capacity signaling (not just a short “boost”). Unifying mechanism: both interventions enhance oxidative metabolism and support neuronal survival under stress. Paper reviews multiple model contexts (ischemia, trauma, neurotoxicity, neurodegeneration models, etc.) as “shared bottleneck” evidence. Practical translation emphasis: target access matters (MB crosses BBB; NIR can reach cortical tissue with correct parameters). Key caution: mechanism ≠ guaranteed clinical proof; these are credible mitochondrial-support tools, not universal cures. - Episode timeline 0:19–0:34 — Show open + why this paper matters 0:34–1:20 — Core premise: different tools, same mitochondrial target 1:22–2:24 — “Neuron as a city” model: neurodegeneration as failing power plants 2:24–4:24 — Methylene blue explained: electron transport chain “extra courier” + hormetic dosing 4:24–5:15 — Cytochrome oxidase focus: why boosting the “end-of-line turbine” matters 5:15–7:24 — Near-infrared light mechanism: photons → cytochrome oxidase → ATP + longer-lasting effects 7:24–8:55 — The unifying mechanism: respiration support → wider “energy margin” → neurons harder to kill 8:55–10:29 — Evidence across models + “target access” (BBB penetration; transcranial penetration) 10:29–11:43 — Why energy support unlocks repair/plasticity outputs (BDNF, synaptogenesis, etc.) 11:43–12:34 — Hormesis again: the “sweet spot” principle for MB and light 12:34–15:25 — Synthesis + disciplined conclusion (not cures; mitochondrial respiration is the lever) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    16 min

  3. 4D AGO

    Shilajit for Real Performance: The “Strength-Under-Fatigue” Study

    In this Energy Code Deep Dive episode, Dr. Mike breaks down a practical 8-week human study on shilajit and performance where it actually matters: after fatigue sets in. Recreationally active young men took placebo, 250 mg/day, or 500 mg/day, then got pushed through a brutal leg-extension fatigue protocol to see how much strength they lost — not just how strong they were fresh. The standout finding: in the stronger half of subjects, the 500 mg group preserved significantly more maximal isometric strength post-fatigue — and showed a quieter signal on serum hydroxyproline, a marker often used to reflect collagen/connective-tissue turnover. Bottom line: this paper doesn’t claim “instant strength.” It suggests shilajit may be more interesting as a fatigue-resistance + tissue-support tool — at the right dose, in the right population. (Educational content only, not medical advice.) - Article Discussed in Episode: The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels - Key Quotes From Dr. Mike: “In that stronger subgroup, the high dose shilait group lost significantly less maximal isometric strength after the fatiguing protocol…” “So in simple terms, the men taking 500 mg per day of Sheelajit held on to their strength better once fatigue hit.” “This was not a study showing Shilait magically blocks exercise damage… It is more a study suggesting that over time, the higher dose may support the tissue environment…” “The strongest and cleanest finding is this… 500 mg per day… helped preserve maximal strength better after fatigue…” “Sometimes performance support is not about creating more force at the start. Sometimes it is about losing less force when fatigue tries to take it away.” - Key Points The study asks a real-world question: how much strength do you lose when you’re tired? Design: recreationally active young men; placebo vs 250 mg/day vs 500 mg/day for 8 weeks. Test: maximal isometric strength pre-fatigue, then 2×50 maximal concentric isokinetic leg extensions, then post-fatigue testing. Primary performance signal showed up in the upper 50% (stronger subjects): 500 mg/day = less post-fatigue strength loss. The lower dose (250 mg/day) did not clearly separate from placebo in that stronger subgroup. Hydroxyproline (HYP) was used as an indirect marker of collagen/connective-tissue breakdown. In the stronger subgroup, the 500 mg/day group had lower baseline HYP vs low dose and placebo after supplementation. No big claims of “massive strength gain,” “weight change,” or “muscle growth.” The story is fatigue-retention, not “overnight PRs.” Mechanistic framing is suggestive (ATP/mitochondrial support is discussed), but the study itself is performance + serum marker, not deep mitochondrial assays. Limitations: young men only, specific fatigue model (concentric-dominant), and funding/source considerations. - Episode timeline 0:19–0:34 — Show open + setup for a shilajit performance Deep Dive 0:34–1:30 — The question: 8 weeks of shilajit—does it help strength retention under fatigue + connective tissue signals? 1:38–2:14 — What shilajit is (Ayurvedic mineral-rich exudate; fulvic acids, DBPs, minerals) 2:14–2:58 — Study design: placebo vs 250 mg/day vs 500 mg/day; 8-week supplementation 2:40–3:22 — The fatigue protocol + why “strength loss under fatigue” is the real-world metric 3:27–4:14 — Hydroxyproline explained as a collagen/connective-tissue breakdown signal 4:15–5:01 — Main finding: overall modest, but stronger subgroup shows a clearer effect 4:29–5:36 — Headline: 500 mg/day group lost less maximal isometric strength post-fatigue (in stronger half) 5:36–6:09 — Dose specificity: 250 mg/day didn’t separate clearly; possible threshold effect at 500 mg 6:13–7:38 — Hydroxyproline results + why the concentric-only protocol matters for interpretation 7:59–9:04 — Mechanistic framing (ATP/mitochondria discussion as a plausible lens) 9:04–10:31 — What the study did not show + disciplined interpretation 10:35–11:15 — Limitations + conflict-of-interest note 11:19–13:49 — Synthesis: shilajit as “hold the line under fatigue” support + wrap - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    14 min

  4. 5D AGO

    BioShilajit: Stop Borrowing Energy From Tomorrow (The 3-Part Mitochondrial Stack)

    Dr. Mike unveils BioShilajit — a “trio stack” built for mitochondrial performance: shilajit for ionic minerals + fulvic/humic support, PQQ to signal mitochondrial biogenesis (PGC-1α), and pharmaceutical-grade methylene blue as a low-dose electron-cycling “failsafe” for the respiratory chain. Along the way, he breaks down why chronic fatigue and brain fog often evade standard labs, walks through the origin story and chemistry of shilajit, highlights ATP and endurance data, explains PQQ’s unique role in building new “cellular engines,” and tells the bizarre history of methylene blue — from textile dye to essential emergency medicine — before tying it all together as structure + supply + backup mechanics for cellular energy. He closes with launch details, the first-week discount code, and where to find the full resource library on the BioLight product page. (Educational content only, not medical advice.) - Article Discussed in Episode: Fullerenes as Anti-Aging Antioxidants - Key Quotes From Dr. Mike: Regarding BioShilajit: "A mountain resin, a bacterium, and a clothing dye… sounds like quite the trio.” “Shilajit roughly translates to: the conqueror of mountains and destroyer of weakness.” “Shilajit contains over 85 distinct trace minerals — and the key word is bioavailable.” “Shilajit is the pharmacological opposite of a stimulant — it doesn’t tape over the check-engine light; it helps the cell produce more of its own ATP.” “A microscopic picomolar concentration of PQQ can execute thousands — sometimes tens of thousands — of redox cycles without breaking down.” “PQQ triggers this exact same genetic alarm bell (PGC-1α -> mitogenesis) — but without the ten-mile run.” “Inside damaged mitochondria, methylene blue’s mechanism is bypassing the blockade (blockages in the ETC).” - Key Points Two BioLight events + one roadmap: Beyond Conference (Austin, May 27–29), Return to Nature (Franklin, June 11–12), and a tentative A4M plan (December). Core thesis: chronic fatigue/brain fog often reflects micro-level mitochondrial “power grid” failure, not a single broken marker on standard labs. BioShilajit = “unlikely trio”: shilajit + PQQ + methylene blue designed as a closed-loop energy system. Shilajit basics: paleo-humus resin rich in fulvic/humic acids, DBP-like compounds, and ionic trace minerals for high absorption. ATP angle: shilajit framed as ATP preservation + ETC enzyme protection under stress (mouse forced-swim model described). Stimulant vs metabolic: shilajit positioned as the opposite of “masking fatigue” (caffeine analogy). PQQ: framed as a catalytic redox molecule tied to mitochondrial biogenesis via PGC-1α / CREB signaling. Methylene blue: framed as a low-dose electron cycler that can bypass bottlenecks in the ETC, especially relevant to brain energy. Safety/precision: strong emphasis on dose hormesis + USP pharmaceutical grade only (avoid aquarium/industrial impurities). - Episode timeline 00:01:07–00:03:37 — Beyond Conference (Austin, May 27–29): booth location + product teases 00:03:56–00:05:58 — Speaking topics + Return to Nature (Franklin, June 11–12) + vibe contrast 00:06:13–00:06:51 — Tentative A4M (December) + lead-in to minerals line 00:06:51–00:07:59 — Minerals stack → pivot to BioShilajit announcement 00:07:59–00:10:23 — Why “binary medicine” fails fatigue/brain fog; “wrong level” diagnosis 00:10:24–00:12:34 — The “unlikely trio” frame: mountain resin + bacterial cofactor + blue dye 00:12:43–00:16:40 — Shilajit origin stories + sensory reality + what it is (paleo-humus) 00:20:14–00:22:17 — Molecular payload: fulvic/humic acids + trace minerals + safety/purity note 00:22:26–00:29:32 — Evidence + mechanisms: ATP/fatigue model + “not a stimulant” analogy 00:29:32–00:34:02 — Hormones + cognition: testosterone study overview + tau aggregation discussion 00:34:02–00:39:10 — Shilajit “matchmaker” model: fulvic delivery + DBP-style mitochondrial cleanup 00:39:10–00:48:53 — PQQ deep dive: discovery, “vitamin-like” role, redox cycling, biogenesis signaling 00:49:24–01:05:24 — Methylene blue: history → ETC bypass model → brain relevance → dose/sourcing warnings 01:05:24–01:12:25 — Closed-loop synergy: build engines (PQQ) + supply/protect (shilajit) + failsafe (MB) 01:12:25–01:15:48 — Launch details + discount code + deadline (through May 7) 01:15:54–01:18:41 — Product page “mini-library” + shoutout + closing - For the next week, save 20% on your order of BioShilajit!   And for the next week ONLY, you can combine this 20% discount with the Subscribe and Save 10% discount option* (choose on the product page when adding to cart).   This limited-time offer provides you with a 30% discount on BioShilajit and you will retain this exclusive discount of the lifetime of your subscription.   Discount code: BIOSHILAJIT20   Expires on 5/7, midnight PST   *must choose "Single" quantity option and then increase to desired amount   Shop BioShilajit! - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    1h 20m

  5. 6D AGO

    C60 Fullerenes: The Soccer-Ball Molecule That Might Slow Aging

    What if one of the strangest molecules in biology — the carbon “nanoball” known as C60 — could meaningfully influence aging? In this Energy Code Deep Dive, Dr. Mike breaks down the paper “Fullerenes as Anti-Aging Antioxidants” and explores why fullerenes have become a lightning-rod topic in longevity. You’ll learn what fullerenes are, why their electron-handling chemistry makes them different from typical antioxidants, and how the review frames their potential role in oxidative stress and mitochondrial function. We unpack the famous C60-in-olive-oil lifespan study, the proposed mechanisms (from “radical sponge” behavior to a more strategic mitochondrial ROS-reduction hypothesis), and the most important caveat: context and formulation can flip the biology. Preparation, dose, impurities, and even light exposure can shift fullerenes from promising to problematic—so this episode is about the science, the signal, and the safety questions that still need answers. (Educational content only, not medical advice.) - Article Discussed in Episode: Fullerenes as Anti-Aging Antioxidants - Key Quotes From Dr. Mike: “These molecules (Carbon 60) can accept electrons… interact with free radicals… and move through lipid membranes.” “ROS are like sparks coming off a machine… a few sparks are normal, too many sparks start causing damage.” “Fullerenes can accumulate in mitochondria… placing a fire extinguisher inside the power plant itself.” “Now the fullerene is not just cleaning up sparks after they happen, it may be reducing how many sparks the mitochondrial power plant throws off in the first place.” “Sometimes the most interesting ideas in anti-aging science are not the ones that sound familiar.” - Key Points What fullerenes are: spherical carbon cages; C60 = 60 carbon atoms in a “soccer-ball” structure. Why the hype exists: they can accept electrons, interact with free radicals, and move through lipid membranes. Aging framework: ties into the free radical/mitochondrial oxidative stress model of aging. The headline animal finding: C60 dissolved in olive oil was associated with a large lifespan increase in rats (not a human claim). How they may work: not only scavenging ROS, but possibly triggering protective pathways. Mitochondria angle: evidence suggests mitochondrial accumulation, potentially changing ROS “at the source.” Provocative mechanism hypothesis: fullerenes may behave like a mild “pressure release valve” (uncoupler-like behavior) in mitochondria. Critical caution: biology is context-dependent — prep, dose, surface chemistry, impurities, and light can shift effects. Safety reality: mixed findings across studies; the review treats this as a platform with variable outcomes. Bottom line: compelling early signals, but not a validated human anti-aging therapy. - Episode timeline 0:47–1:41 — What fullerenes are: C60, the carbon “soccer ball” 1:41–2:18 — Why longevity cares: electrons, radicals, membranes, mitochondria 2:19–3:35 — Free-radical theory → mitochondria as the “spark source” 3:46–4:16 — The non-simple story: beneficial vs harmful effects 4:23–5:30 — Anti-aging evidence overview + the famous C60/olive-oil rat study (with realism) 5:54–6:33 — “Radical sponge” concept + SOD-mimic derivatives 6:42–7:31 — City analogy + the idea that fullerenes may also trigger endogenous defenses 7:40–9:38 — Mitochondria deep dive: accumulation + mild “uncoupler/pressure-valve” hypothesis 10:03–11:23 — Toxicity + why formulation and context can flip outcomes 11:24–12:11 — Broad application claims + why that’s both exciting and cautionary 12:11–15:21 — The real takeaway: promise, limits, unanswered questions + closing - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    16 min

  6. APR 28

    Better Mitochondria, Not Just More: Urolithin A’s Human Trial Explained

    In this Deep Dive episode, Dr. Mike breaks down a landmark first-in-human study on urolithin A — one of the most important translational steps yet in mitochondrial longevity science. The paper asks the question the field has been waiting for: when you target mitophagy (the selective cleanup of damaged mitochondria) in real humans, does it appear safe, does it reach the bloodstream and tissue, and does it actually shift biology in the direction of healthier mitochondrial function? You’ll learn why urolithin A is different from typical “mitochondria boosters,” how the study tested safety, tolerability, and bioavailability, and why it matters that urolithin A was detected in skeletal muscle. Dr. Mike also explains the key biomarker signals—like reductions in plasma acylcarnitines — and the muscle gene-expression changes that suggest a coordinated mitochondrial health signature, including comparisons to patterns seen in healthier, more active older adults. The takeaway: this study doesn’t prove performance gains yet — but it strongly supports that mitochondrial quality control is a targetable human biology, and it opens the door for larger efficacy trials. (Educational content only, not medical advice.) - Article Discussed in Episode: The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans - Key Quotes From Dr. Mike: “Aging is also the progressive failure of mitochondrial quality control.” “Instead of just trying to stimulate mitochondria harder… (with urolithin A) you are trying to improve the quality of the mitochondrial population itself.” “Urolithin A was detectable in skeletal muscle after oral dosing…” “This is not just a paper saying urolithin A is present in blood… the muscle is responding with a transcriptional program consistent with improved mitochondrial health.” “The molecular signature induced by urolithin A resembles aspects of what is seen with regular exercise.” - Key Points Why it matters: A “mitophagy-first” intervention is tested in humans, not just cells or animals. Study design: Randomized, double-blind, placebo-controlled Phase 1 in healthy sedentary older adults, with single- and multiple-ascending dose arms (28 days). Safety: Favorable profile, no serious adverse events reported; no major lab/ECG concerns noted in the transcript. Bioavailability: Detectable in plasma across doses; dose-dependent exposure from 250–1000 mg. Tissue access: Detectable in skeletal muscle, which is critical for the aging-muscle thesis. Metabolic signal: Reduced plasma acylcarnitines, consistent with improved mitochondrial fuel handling. Muscle response: Dose-dependent upregulation of mitochondrial/mitophagy-related gene programs; examples mentioned include GABARAPL1 and FABP3. Systems-level finding: Gene-set patterns shift toward a profile more consistent with healthier muscle biology. Exercise resemblance: The molecular signature overlaps with aspects of exercise adaptation — without claiming equivalence. Limitation: No functional endpoints (strength, walking speed) due to short duration — this is a foundational mechanistic/PK/biomarker study. - Episode timeline 0:51–1:34 — Why this paper is a “turning point” (from mice to humans) 1:34–2:38 — What urolithin A is + why mitophagy is the target 2:38–3:47 — Aging as mitochondrial quality-control failure; why muscle is the proving ground 3:47–4:46 — Trial design: randomized, double-blind, placebo-controlled Phase 1; single vs multiple ascending dose 4:46–5:39 — Safety & tolerability overview 5:39–6:57 — Pharmacokinetics: plasma exposure, dose-dependence, conjugates, and skeletal muscle detection 6:57–7:36 — Practical translational detail: minimal food effect (yogurt matrix) 7:36–9:14 — Biomarker signal: acylcarnitines as a window into fatty-acid oxidation efficiency 9:14–10:57 — Muscle biopsy findings: gene expression shifts (mitophagy/mitochondrial programs) 10:57–12:29 — Transcriptomics + “directional rescue” vs pre-frail sedentary signatures 12:29–13:53 — Exercise-like signature (with explicit caveats) 13:53–14:57 — Limitations: no performance outcomes yet; why that’s expected in 4 weeks 14:57–16:25 — Evidence hierarchy: safety → PK → biomarkers → then larger trials 16:25–17:07 — Why supplementation matters: microbiome variability makes food-derived production inconsistent 17:07–19:31 — Final synthesis: mitophagy/quality control as a targetable human pathway + closing - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    20 min

  7. APR 27

    Mitochondria Don’t Just “Decline” With Age — They Lose Adaptability (And That May Be the Real Aging Engine)

    In this Energy Code Deep Dive, Dr. Mike unpacks Mitochondria at the Heart of Aging: Structure, Function, and Failure — a sweeping review arguing that aging isn’t just random damage over time, but a progressive loss of mitochondrial adaptability. The episode walks through the core failure loops that accelerate aging across tissues: mtDNA instability → impaired oxidative phosphorylation → rising ROS → more mtDNA damage, plus breakdowns in fusion/fission architecture, mitophagy and quality control, NAD⁺ metabolism and sirtuin resilience, and the inflammatory spillover that turns mitochondrial stress into inflammaging. The key takeaway: mitochondria aren’t background “powerhouses” — they’re a systems-level coordinator of redox, metabolism, cleanup, and stress responses, and aging may be the gradual loss of that mitochondrial “intelligence.” (Educational content only, not medical advice.) - Article Discussed in Episode: Mitochondria at the heart of aging: structure, function, and failure - Key Quotes From Dr. Mike: “Aging is not just reducing mitochondrial quantity, it is degrading mitochondrial architecture.” “Mitochondrial aging is a network problem, not a single molecule problem.” “Aging is in part the loss of mitochondrial intelligence.” “Not all tissues age the same way mitochondrially.” “We are not just trying to stimulate energy. We are trying to restore mitochondrial adaptability.” - Key Points Central thesis: Aging = loss of mitochondrial adaptability, not just lower ATP. Mitochondria as aging hub: redox control, apoptosis, inflammation coordination, metabolic flexibility, QC. Hallmarks link: mitochondrial dysfunction interacts with genomic instability, senescence, inflammaging, proteostasis loss, stem cell exhaustion. mtDNA vicious cycle: mtDNA mutations/deletions → weaker OXPHOS → more ROS → more mtDNA damage. Tissue vulnerability: post-mitotic, high-demand tissues (brain, heart, skeletal muscle) are hit hardest. Dynamics failure: imbalance in fusion (MFN1/2, OPA1) and fission (DRP1) → fragmentation + crista disruption + reduced stress tolerance. Mitophagy decline: PINK1/Parkin + BNIP3/NIX/FUNDC1 pathways weaken → damaged mitochondria accumulate. Inflammaging bridge: mtDNA/ROS/cardiolipin danger signals activate cGAS–STING and NLRP3. NAD⁺ collapse loop: NAD⁺ decline → weaker SIRT1/SIRT3 → lower resilience; dysfunction also worsens NAD⁺ regeneration. MIDAS concept: mitochondrial dysfunction can directly drive senescence (not just nuclear DNA damage). Intervention framing: reduce damage + improve clearance + restore function (but calibration matters: mitohormesis, too much/too little mitophagy). Translation realism: biomarkers, delivery, long-term safety, and tissue-specific effects remain limiting factors. - Episode timeline 0:33 — Paper setup + thesis: aging as loss of mitochondrial adaptability 1:32 — Mitochondria as more than ATP: redox, stress signaling, apoptosis, inflammation, flexibility, QC 2:28 — Mitochondria woven into hallmarks of aging (senescence, proteostasis, inflammaging, etc.) 3:23 — mtDNA damage + the core vicious cycle (OXPHOS decline → ROS → more damage) 4:18 — Why post-mitotic tissues (brain/heart/muscle) are uniquely vulnerable 4:59 — Mitochondrial dynamics: fusion/fission balance and aging-related fragmentation 6:35 — Quality control failure: why the cell can’t just “clean it up” forever 7:00 — Mitophagy pathways (PINK1/Parkin; BNIP3/NIX/FUNDC1) + consequences of decline 8:08 — Mitophagy failure → danger signals → cGAS–STING / NLRP3 → inflammaging 9:13 — NAD⁺ metabolism: SIRT1/SIRT3 dependence and feed-forward decline loops 11:32 — MIDAS: mitochondrial dysfunction–associated senescence as a distinct route 13:01 — Interventions framework: reduce damage / enhance clearance / restore function 13:49 — Nuance: mitohormesis + “calibrated restoration” (no one-way levers) 14:59 — Urolithin A + combination logic (clearance + biogenesis; coordinated restoration) 16:01 — Barriers: biomarkers, delivery, tissue heterogeneity, translation into older humans 16:50 — Final synthesis: aging as loss of mitochondrial “intelligence” and adaptive coordination - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    20 min

  8. APR 25

    Methylene Blue vs. Asthma: Can a Redox Molecule Calm Inflammation & Oxidative Stress?

    In this Energy Code Deep Dive, Dr. Mike breaks down a preclinical paper testing methylene blue in a classic ovalbumin (OVA)–induced allergic asthma mouse model. The core question: if allergic asthma is driven by a self-reinforcing loop of TH2 cytokines (IL-4, IL-13), IgE signaling, eosinophilic airway infiltration, and oxidative stress, can a redox-active compound interrupt the cycle? The study reports dose-dependent improvements across airway inflammation (BALF immune cells), immune programming (IL-4/IL-13 + OVA-specific IgE), oxidative damage (MDA), antioxidant defenses (GSH/GPx), and lung histology — while emphasizing the key caveat: this is not human clinical asthma, and safety/translation questions remain open. (Educational content only, not medical advice.) - Article Discussed in Episode: Methylene blue attenuates ovalbumin-induced airway inflammation and oxidative stress in mouse model of asthma - Key Quotes From Dr. Mike: “Oxidative stress is not a side issue in asthma, it is part of the disease mechanism.” “Eosinophilia is one of the hallmarks of allergic asthma.” “Methylene blue significantly reduced those IgE levels… in a dose-dependent manner.” “Both cytokines were significantly elevated… and methylene blue… significantly lowered both of them.” “This is a proof of concept study, and as a proof of concept, it is strong.” - Key Points Model: OVA + alum sensitization, then inhaled OVA challenge (TH2-driven allergic asthma in mice). Intervention: methylene blue 10 vs 20 mg/kg. Inflammation: reduced BALF leukocytes, especially eosinophils (dose-dependent). Immune signaling: lowered IL-4 and IL-13 (TH2 axis), dose-dependent. Allergy amplifier: lowered OVA-specific IgE (dose-dependent). Oxidative stress: decreased MDA (lipid peroxidation marker). Antioxidant defenses: increased GSH and GPx. Tissue-level confirmation: histology showed less peribronchial/perivascular inflammatory infiltration. Translation caution: murine acute allergic model ≠ clinical asthma outcomes (AHR, symptoms, remodeling). Safety realism: methylene blue has side effects + drug interactions that matter in humans. - Episode timeline 0:34 — Paper setup: asthma + oxidative stress + why methylene blue is interesting 1:49 — Model overview: OVA-induced allergic asthma (TH2 inflammation) 2:13 — Study design: 10 vs 20 mg/kg MB + endpoints (BALF, cytokines, oxidative markers, histology, IgE) 3:14 — Why MB could matter: redox, anti-inflammatory, mitochondria-adjacent logic 4:14 — TH2 biology refresher: IL-4 → IgE; IL-13 → mucus/remodeling/hyperreactivity 5:17 — BALF results: reduced leukocytes/eosinophils/lymphocytes/neutrophils (dose response) 7:06 — IgE results: OVA-specific IgE drops with MB (dose response) 8:01 — Cytokines: IL-4 and IL-13 reduced (dose response) 9:19 — Oxidative stress panel: MDA down; GSH + GPx up 11:53 — Histology: less inflammatory infiltration; scores improve (dose response) 13:15 — Translation + safety cautions: mouse model, not clinical asthma; side effects/interactions 14:22 — Broader synthesis: asthma as an inflammation–redox loop; MB as a “clue” for redox therapies 15:35 — Closing summary + take-home message - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

    18 min
See All (333)

4.8
out of 5
126 Ratings

About

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

Information

  • Creator
    Dr. Mike Belkowski
  • Years Active
    2021 - 2026
  • Episodes
    333
  • Rating
    Clean
  • Copyright
    © Copyright 2021 All rights reserved.
  • Show Website
    The Energy Code

You Might Also Like